Alzamend Neuro
Price & Volume
Stats
See moreOpen | $0.97 |
Previous Close | $1 |
Day Range | $0.97-$1.01 |
52W Range | $0.64-$9.90 |
Market Cap | $6.6M |
Shares Short | 52,811 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$134.51 |
News
See moreYahoo Finance • 24 days ago
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital
Yahoo Finance • last month
Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital
Yahoo Finance • 12 months ago
Insiders Are Buying These 11 Penny Stocks
Yahoo Finance • 3 years ago
10 Biotech Penny Stocks with Growth Catalysts
About
CEO | Mr. Stephan Jackman |
Address | 3480 Peachtree Road NE, Atlanta, GA, United States, 30326 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
